Technical Article - Improving bioavailability & solubility: understand your molecule

Read an article at Drug Development & Delivery magazine addressing bioavailability (BA) and low solubility challenges.

Like Comment

David Lyon says amorphous solid dispersions (ASDs) and lipid-based formulations are two enabling technologies that can accelerate bioavailability-challenged molecules to clinic and market––backed by Lonza’s SimpliFiH™ Solutions. 

Don`t forget to register for our upcoming webinars:

Lonza Pharma & Biotech

At Lonza Pharma & Biotech we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome, at the time when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just the current, but also the future challenges. Together, we can bring your next medicine to life.
5 Contributions
0 Following